29
/
en
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 15, 2023
Create
Public Timelines
Library
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
Download
Export
Duplicate
Embed
Edit
222 views
0
0
asdfg
Created by
Daniel Rossi
⟶ Updated 16 Oct 2017 ⟶
List of edits
Comments
Events
Founded as Genetix Pharmaceuticals
Jesse Gelsinger Dies, Interest Lost in Gene Therapy
Series A Financing, $20 million raised
Phase I/II Beta Thallassemia trial launched
Genetix Launches ADL Program
Series B, $35 million raised, new CEO from Third Rock Ventures
Series C, $35 million
Series D, $60 million
Initial Public Offering, $116 million
Cash assets expected to run out
Phase 3 End Date, Beta Thalassemia
Phase 2/3 end date, ALD
